Neuroendocrine tumours trials in Japan

In Japan 6 Also abroad 244

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Chuo-ku, Kyoto, Nankoku, Sapporo, Tokyo, Yokohama
Age
12 years and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
Phase 3Taking people
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Where
Aichi, Nagoya, Chiba, Kashiwa, Ehime, Matsuyama, Fukuoka, Fukuoka, Hokkaido, Sapporo, Ishikawa, Kanazawa, Kanagawa, Yokohama, Kyoto, Kyoto, Miyagi, Sendai, Okayama, Okayama, Osaka, Osaka, Shizuoka, Sunto-gun, Tokyo, Chuo-ku
Age
18 years and over
People
390 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00
Phase 1/2Not yet taking people in Japan
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
Where
Hokkaido, Sapporo, Kanagawa, Kawasaki, Osaka, Hirakata, Shizuoka, Sunto-gun
Age
18 years and over
People
60 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07707895 · EU 2026-525634-27-00
Phase 1Taking people
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Where
Chuo Ku
Age
18 years to 100 years
People
116 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00
Phase 2Taking people
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Where
Aichi, Nagoya, Chiba, Kashiwa, Miyagi, Sendai, Osaka, Osaka, Osaka, Sakai, Tokyo, Chuo-ku, Tokyo, Koto-ku
Age
18 years and over
People
204 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00
Phase 1/2Taking people
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Where
Chuo Ku, City
Age
18 years and over
People
27 worldwide
Run by
Tanabe Pharma America, Inc.
See details and how to joinNCT06943521